Shares of Arena Pharmaceuticals jumped 3.13% to $75.72 at 12:42 EST on Tuesday, after five successive sessions in a row of gains. The Nasdaq Stock Market is jumping 0.16% to $12,762.70, after two successive sessions in a row of losses. This seems, at the moment, a somewhat positive trend exchanging session today.

Arena Pharmaceuticals’s last close was $73.42, 19.11% below its 52-week high of $90.19.

Arena Pharmaceuticals’s Sales

Arena Pharmaceuticals’s sales growth is a negative 81.3% for the ongoing quarter and 155.7% for the next. The company’s growth estimates for the present quarter is a negative 4.5% and positive 4.5% for the next.

Arena Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.

Arena Pharmaceuticals’s Stock Yearly Top and Bottom Value

Arena Pharmaceuticals’s stock is valued at $75.72 at 12:42 EST, way below its 52-week high of $90.19 and way above its 52-week low of $32.95.

Arena Pharmaceuticals’s Moving Average

Arena Pharmaceuticals’s worth is above its 50-day moving average of $70.78 and higher than its 200-day moving average of $69.59.


Please enter your comment!
Please enter your name here